Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. [electronic resource]
Producer: 20120604Description: 120ra17 p. digitalISSN:- 1946-6242
- Anaplastic Lymphoma Kinase
- Cell Line, Tumor
- Crizotinib
- Drug Resistance, Neoplasm -- genetics
- Humans
- Immunoblotting
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Lung Neoplasms -- drug therapy
- Mutation
- Polymerase Chain Reaction
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyridines -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.